Discovery of type IV collagen non-collagenous domains as novel integrin ligands and endogenous inhibitors of angiogenesis.
Kalluri
R
R
Program in Matrix Biology, Department of Medicine, Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA.
D020533:Angiogenesis Inhibitors / Q000494:pharmacology; D000818:Animals; D001324:Autoantigens / Q000378:metabolism / Q000494:pharmacology; D001485:Basement Membrane / Q000378:metabolism; D024141:Collagen Type IV / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism* / Q000494:pharmacology; D006801:Humans; D016023:Integrins / Q000378:metabolism*; D008024:Ligands; D008958:Models, Molecular; D009389:Neovascularization, Pathologic / Q000188:drug therapy; D018919:Neovascularization, Physiologic / Q000187:drug effects; D010446:Peptide Fragments / Q000378:metabolism; D017434:Protein Structure, Tertiary
D020533:Angiogenesis Inhibitors; D001324:Autoantigens; D024141:Collagen Type IV; D016023:Integrins; D008024:Ligands; D010446:Peptide Fragments; C057112:type IV collagen alpha3 chain